Skip to content
Disclosery

CITADEL ADVISORS LLC: IVES position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of CITADEL ADVISORS LLC on IVES, newest first. How the timeline and the estimate are built.

CITADEL ADVISORS LLC held 60,187 IVES shares at 2026-06-30 per its 13F-HR/A filed 2026-09-02.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F/A 60,187 shares
    Change vs previous 13F +45,808 shares

    <0.01% of the 13F portfolio, value $2,293,125.

    13F-HR/A 0001104659-26-104387 filed by CITADEL ADVISORS LLC
    Accepted , ingested

  2. period ended2026-03-31
    13F 14,379 shares
    Change vs previous 13F -95,239 shares

    <0.01% of the 13F portfolio, value $407,932.

    13F-HR 0001104659-26-062477 filed by CITADEL ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 109,618 shares
    Change vs previous 13F -33,604 shares

    <0.01% of the 13F portfolio, value $3,465,025.

    13F-HR 0001104659-26-016408 filed by CITADEL ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 143,222 shares
    Change vs previous 13F -36,701 shares

    <0.01% of the 13F portfolio, value $4,600,291.

    13F-HR 0001104659-25-112514 filed by CITADEL ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 179,923 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $4,877,713.

    13F-HR 0001104659-25-078555 filed by CITADEL ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).